Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ImmunoCellular Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 10
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
ImmunoCellular Therapeutics to Enter into Agreement with Memgen 13
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 14
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 15
ImmunoCellular Therapeutics Enters into Agreement with Canadian Brain Tumour Consortium 16
ImmunoCellular Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 17
ImmunoCellular Therapeutics Enters into Agreement with Pure MHC 18
Licensing Agreements 19
ImmunoCellular Therapeutics Enters into Licensing Agreement with California Institute of Technology 19
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 20
ImmunoCellular Amends Licensing Agreement With Johns Hopkins University 21
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 22
Equity Offering 23
ImmunoCellular Therapeutics Raises USD5 Million in Public Offering of Units 23
ImmunoCellular Therapeutics Files for Rights Offering 25
ImmunoCellular Therapeutics Prices Public Offering of Shares and Warrants for USD7.5 Million 26
ImmunoCellular Plans to Raise Funds through Public Offering of Shares 28
ImmunoCellular Therapeutics Raises USD16 Million in Public Offering of Shares and Warrants 29
ImmunoCellular Therapeutics Decreases Size Of Public Offering Of Shares For US$17 Million 30
ImmunoCellular Therapeutics Completes Public Offering Of Shares For US$21 Million 31
ImmunoCellular Therapeutics Completes Public Offering Of Units For US$10.4 Million 33
ImmunoCellular Therapeutics Ltd – Key Competitors 34
ImmunoCellular Therapeutics Ltd – Key Employees 35
ImmunoCellular Therapeutics Ltd – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 36
Recent Developments 37
Financial Announcements 37
Aug 13, 2018: ImmunoCellular Therapeutics provides corporate update and reports second quarter 2018 financial results 37
May 14, 2018: ImmunoCellular Therapeutics Reports First Quarter 2018 Financial Results 39
Mar 13, 2018: ImmunoCellular Therapeutics Reports Fourth Quarter And Full Year 2017 Financial Results 40
Nov 21, 2017: ImmunoCellular Therapeutics Announces Third Quarter 2017 Financial Results 41
Aug 14, 2017: ImmunoCellular Therapeutics Announces Second Quarter 2017 Financial Results 42
May 15, 2017: ImmunoCellular Therapeutics Announces First Quarter 2017 Financial Results 43
Mar 09, 2017: ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 44
Product News 46
12/13/2017: ImmunoCellular Therapeutics Achieves Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program 46
Apr 12, 2018: ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program 47
Other Significant Developments 48
Feb 13, 2018: ImmunoCellular Therapeutics Announces Update on Financial Condition 48
Aug 23, 2017: ImmunoCellular Therapeutics Provides Business Update on Research and Development Programs and Future Strategy 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ImmunoCellular Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
ImmunoCellular Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 10
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ImmunoCellular Therapeutics to Enter into Agreement with Memgen 13
ImmunoCellular Therapeutics Enters into Research Agreement with Stanford University 14
ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore 15
ImmunoCellular Therapeutics Enters into Agreement with Canadian Brain Tumour Consortium 16
ImmunoCellular Therapeutics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 17
ImmunoCellular Therapeutics Enters into Agreement with Pure MHC 18
ImmunoCellular Therapeutics Enters into Licensing Agreement with California Institute of Technology 19
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 20
ImmunoCellular Amends Licensing Agreement With Johns Hopkins University 21
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 22
ImmunoCellular Therapeutics Raises USD5 Million in Public Offering of Units 23
ImmunoCellular Therapeutics Files for Rights Offering 25
ImmunoCellular Therapeutics Prices Public Offering of Shares and Warrants for USD7.5 Million 26
ImmunoCellular Plans to Raise Funds through Public Offering of Shares 28
ImmunoCellular Therapeutics Raises USD16 Million in Public Offering of Shares and Warrants 29
ImmunoCellular Therapeutics Decreases Size Of Public Offering Of Shares For US$17 Million 30
ImmunoCellular Therapeutics Completes Public Offering Of Shares For US$21 Million 31
ImmunoCellular Therapeutics Completes Public Offering Of Units For US$10.4 Million 33
ImmunoCellular Therapeutics Ltd, Key Competitors 34
ImmunoCellular Therapeutics Ltd, Key Employees 35
ImmunoCellular Therapeutics Ltd, Subsidiaries 36
ImmunoCellular Therapeutics Ltd, Joint Venture 36
List of Figures
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ImmunoCellular Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ImmunoCellular Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 10